drugset / Trial / NCT00376857

Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green.

NCT00376857 ↗

Completed 60 enrolled University of Regensburg
RandomizedParallel-groupSingle-blindTreatment

Summary

It was the aim of the present study to prospectively compare the functional and morphological outcome of idiopathic epiretinal membrane surgery with and without the assistance of Indocyanine green (ICG). The main outcome measure was improvement of best-corrected visual acuity (BCVA). This was treated as an open question and we had no hypothesis which of the two therapies was superior.

Timeline

Start
—
Primary completion
—
Completion
—

Outcome

Missed primary endpoint

paper Improvement in BCVA was not statistically significantly different whether ICG was used or not [0.17 (logarithm of minimum angle of resolution; logMAR) with ICG and 0.24 (logMAR) without ICG] (P = 0.59). PMID 17186261 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent 0.1 % —

Indications